Navigation Links
Research on China IVD Reagent (In Vitro Diagnostic Reagent) Industry, 2013-2017
Date:11/19/2013

ages the competitive enterprises to strengthen their strength. In 2013, a series of policies which target to improve industry standard and threshold will enter the substantive operation stage, which will accelerate the elimination of small enterprises and improve the industry concentration ratio, industrial consolidation is the development trend, and the enterprises with capital, technology and scale advantages will win gradually.

In recent years, due to the continued sluggishness of European and American pharmaceutical market, the international giants target on the market expansion brought by China’s new medical reform, and entered China’s market in succession; after the China-oriented R&D center transfer, these powerful enterprises began to compete with China’s enterprises in the low and medium-end markets through mergers, acquisitions, capital increase and production expansion; therefore, the competitive enterprises in China’s diagnostic reagent subdivided industries will face more sever competitions.

Please note: The report is Chinese version. It will provide the English version in two business days.

1. Overview of Diagnostic Reagent Industry
1.1 Definition and Classification
1.1.1 Definition and Classification of Biological Products
1.1.2 Definition and Classification of IVD Reagents
1.2 Development History
1.3 Industry Chain
1.4 Overview of Main Sub-industries
1.4.1 Biochemical Diagnostic Reagent Industry
1.4.2 Immune Diagnostic Reagent
1.4.3 Molecular Diagnostic Reagent

2. Operating Environment of China’s IVD Reagent Industry
2.1 Development Overview of Global IVD Reagent Industry
2.2 Development Overview of China’s Bio-pharmaceutical Industry
2.3 Related Industry Management and Policy
2.3.1 Industry Competent Departments
2.3.2 Industry Supervision System
2.3.3 Main Laws and Regulations
2.3.4 Main
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. UCLA Brain Injury Research Center gets NCAA funding for research on sports concussions
2. NIH awards $20 million over 5 years to train next generation of global health researchers
3. Researchers develop a new cell and animal model of inflammatory breast cancer
4. Researchers uncover a viable way for colorectal cancer patients to overcome drug resistance
5. Sexually abused boys at risk for more unsafe sex: UBC research
6. Researchers Find Gene Mutations That May Be a Key to Autism
7. LSUHSC research finds HPV-related head & neck cancers rising, highest in middle-aged white men
8. Researchers find evidence of banned antibiotics in poultry products
9. Presidential keynote address and new research highlights from the American Society of Pediatric Otolaryngology meeting
10. Scientific session and new research highlights
11. NJ stroke researchers report advances in spatial neglect research at AAN Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... ... July 28, 2015 , ... Scientel is thrilled ... Conference, August 18-20 at the McHenry Convention Center in San Jose, Ca. Scientel ... #104. , Scientel’s presentation on Multi-Modeling and the industry’s first polymorphic database will address ...
(Date:7/27/2015)... SC (PRWEB) , ... July 28, 2015 , ... ... P.A., announced that his practice has teamed up with Realief Neuropathy Centers in order ... been shown to reverse the signs and symptoms of peripheral neuropathy. , Peripheral neuropathy ...
(Date:7/27/2015)... ... July 27, 2015 , ... Specific cardiovascular ... smaller regional brain volumes that may be early indicators of Alzheimer’s disease and ... already know that vascular risk factors damage the brain and can result in ...
(Date:7/27/2015)... , ... July 27, 2015 , ... ... especially in wound center management. Earlier this year Wound Care Advantage ... and training for WCA wound centers. Customized learning paths allow for clinicians, ...
(Date:7/27/2015)... ... July 27, 2015 , ... On July 14, 2015, ... Common Skin Issues,” describes common skin issues such as stretch marks , ... dermatologists to treat them. The treatment options listed include lasers, ultrasound, radio frequency, Botox, ...
Breaking Medicine News(10 mins):Health News:Scientel Selected to Present at 2015 NoSQLNow! Conference, San Jose August 18-20 2Health News:Scientel Selected to Present at 2015 NoSQLNow! Conference, San Jose August 18-20 3Health News:Piedmont Physical Medicine & Rehabilitation, P.A. Partners with Realief® Neuropathy Centers to Offer Peripheral Neuropathy Laser Treatment 2Health News:RSNA: Specific Cardiovascular Risk Factors May Predict Alzheimer’s Disease 2Health News:RSNA: Specific Cardiovascular Risk Factors May Predict Alzheimer’s Disease 3Health News:Wound Care Advantage Launches Luvo University An Online Hub For Wound Care Education and Training 2Health News:Wound Care Advantage Launches Luvo University An Online Hub For Wound Care Education and Training 3Health News:The Latest Treatment Options for Seven Common Skin Issues 2
... availability of Trade Alerts on stocks making news ... notes for free by visiting: http://www.BeaconEquity.com/m Today,s ... Board: UVSE), Green Earth Technologies Inc. (Pink Sheets: ... Gulf Ethanol Corp. (Pink Sheets: GFET), YTB International ...
... 13 Founders Club will donate $5 from the sale ... at St. Joseph,s/Candler. "The Mammography Fund is a great ... fight against cancer," Jeff Andrews, CEO of Founders Club, said.The ... Edwin Watts Golf stores and specialty golf retail stores across ...
... Hill-Rom Holdings, Inc. (NYSE: HRC ) today ... share. This dividend was declared by Hill-Rom,s Board of Directors ... 2009 to shareholders of record as of March 17, 2009. ... is a leading worldwide manufacturer and provider of medical technologies ...
... along with being sweet , , FRIDAY, Feb. 13 (HealthDay News) ... than sweet; it could help guard your true love against ... in addition to being decadent and delicious, moderate amounts of ... Scroggs, a health education manager at the University of Texas ...
... (NYSE Alternext: FHC) announced today that its stock repurchase ... until December 31, 2010. The program was initiated in ... the Company,s common stock through December 31, 2008. In ... and extended until December 31, 2009. Through January 31, ...
... announces that it has implemented cost-cutting measures in order ... will continue to seek financing and will initiate a ... of the Company. , Haemacure has been seeking financing ... expressed interest in an equity financing; however, this interest ...
Cached Medicine News:Health News:Technical Trade Alerts on BeaconEquity OTC Gainers: UVSE, GETG, SRCH, GFET, YTBLA, NTRZ 2Health News:Founders Club Proudly Supports the St. Joseph's/Candler Mammography Fund 2Health News:Chocolate for Your Valentine a Healthy Idea 2Health News:The Female Health Company Expands and Extends Its Stock Repurchase Program 2Health News:The Female Health Company Expands and Extends Its Stock Repurchase Program 3Health News:Haemacure Restructures - Seeks Financing or Sale of the Company 2Health News:Haemacure Restructures - Seeks Financing or Sale of the Company 3
(Date:7/27/2015)... 20, 2015 Research and Markets ( ... "Key Pharma News Issue" newsletter to ... Gilead Sciences, burgeoning oncology pipeline and serves as ... oncology deals in 2015, with a large-scale potentially ... Key Pharma News covers all major ...
(Date:7/27/2015)... , Belgium , July 27, ... VNRX), a life sciences company focused on developing blood-based ... and other conditions, today announced that it has engaged ... organization, Global Specimen Solutions, Inc. (GSS), to support initial ... cancer tests. Under the agreement, GSS ...
(Date:7/27/2015)... IRVINE, Calif. , July 27, 2015 ... ELOS ) , a global market leader in ... has received Korean Ministry of Food and Drug Safety ... this regulatory clearance, the Company can fulfill PicoWay orders ... activity in Korea anticipated later in the third quarter ...
Breaking Medicine Technology:Key Pharma News Issue - Gilead will make further oncology deals in 2015 2Key Pharma News Issue - Gilead will make further oncology deals in 2015 3VolitionRx Engages Specialty Clinical Research Organization to Support Initial Entry of its NuQ(R) Colorectal Cancer Tests via U.S. CLIA Labs 2VolitionRx Engages Specialty Clinical Research Organization to Support Initial Entry of its NuQ(R) Colorectal Cancer Tests via U.S. CLIA Labs 3VolitionRx Engages Specialty Clinical Research Organization to Support Initial Entry of its NuQ(R) Colorectal Cancer Tests via U.S. CLIA Labs 4VolitionRx Engages Specialty Clinical Research Organization to Support Initial Entry of its NuQ(R) Colorectal Cancer Tests via U.S. CLIA Labs 5VolitionRx Engages Specialty Clinical Research Organization to Support Initial Entry of its NuQ(R) Colorectal Cancer Tests via U.S. CLIA Labs 6VolitionRx Engages Specialty Clinical Research Organization to Support Initial Entry of its NuQ(R) Colorectal Cancer Tests via U.S. CLIA Labs 7Syneron Receives Korean MFDS Regulatory Clearance for PicoWay Picosecond Laser 2Syneron Receives Korean MFDS Regulatory Clearance for PicoWay Picosecond Laser 3Syneron Receives Korean MFDS Regulatory Clearance for PicoWay Picosecond Laser 4
... vascular closure device quickly seals ... procedures, allowing for early ambulation ... creates a mechanical seal by ... bio-absorbable anchor and collagen sponge, ...
Terumo's Optitorque offers superior torque and precision control. It's patient-friendly, high torque design makes it the catheter of choice for demanding angiography....
Femoral selective catheter. Catheter material used is polyurethane (DUCOR). Guidewire campatibility is 0.038". Packaging 5/Box....
Femoral selective diagnostic catheter. The material used is nylon (VESTANTM). All selective shapes have thrulumen design. Guidewire campatibility is 0.038". Packaging 5/Box....
Medicine Products: